![]()
Clinical Next-Generation Sequencing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
The global Clinical Next-Generation Sequencing market is predicted to reach a value of $10.6 billion by 2026, with a compound annual growth rate of 13.2%. Market drivers include increasing demand for precision medicine and advancements in NGS technology. Key players in the market include Illumina, Thermo Fisher Scientific, and Pacific Biosciences.
Request Sample Report
◍ Thermo Fisher Scientific
◍ PerkinElmer
◍ Illumina
◍ Beckman Coulter
◍ GATC Biotech
◍ Qiagen
The Clinical Next-Generation Sequencing Market is highly competitive with key players like Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech, and Qiagen dominating the space. These companies provide NGS solutions for various clinical applications, contributing to market growth. Sales revenue figures: Illumina ($3.54B), Thermo Fisher Scientific ($34.1B), Qiagen ($1.53B).
Request Sample Report
◍ Hospitals and Clinics
◍ Biopharma Companies
◍ Academic and Research Organizations
◍ Others
◍ Targeted Sequencing
◍ Exome Sequencing
◍ Others
Request Sample Report
Request Sample Report
$ X Billion USD